PRURIGO NODULARIS
Clinical trials for PRURIGO NODULARIS explained in plain language.
Never miss a new study
Get alerted when new PRURIGO NODULARIS trials appear
Sign up with your email to follow new studies for PRURIGO NODULARIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Real-World dupilumab study aims to ease itchy skin condition
Symptom relief OngoingThis study follows 100 adults with prurigo nodularis, a chronic itchy skin condition, who are already prescribed dupilumab by their doctor. Researchers will track why patients start or stop the drug, how they use it, and whether it reduces hospital visits. The goal is to see how …
Matched conditions: PRURIGO NODULARIS
Sponsor: Sanofi • Aim: Symptom relief
Last updated May 26, 2026 04:53 UTC
-
New pill shows promise for severe itch condition in Late-Stage trial
Symptom relief OngoingThis study tests an experimental drug called povorcitinib in 346 adults with prurigo nodularis, a condition causing intense itching and hard skin bumps. Participants receive either the drug or a placebo to see if it reduces itch and clears lesions over 24 weeks. The goal is to fi…
Matched conditions: PRURIGO NODULARIS
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Symptom relief
Last updated May 26, 2026 04:53 UTC
-
New drug offers hope for chronic itch sufferers
Symptom relief OngoingThis study tests a new medicine called rocatinlimab for adults with prurigo nodularis, a condition causing intense itching and hard bumps on the skin. Participants must have at least 20 nodules and not have gotten relief from creams or ointments. The goal is to see if the drug re…
Matched conditions: PRURIGO NODULARIS
Phase: PHASE3 • Sponsor: Amgen • Aim: Symptom relief
Last updated May 22, 2026 14:05 UTC
-
New drug shows promise for relieving unbearable itch in rare skin disease
Symptom relief OngoingThis study tests an experimental drug called barzolvolimab in 140 adults with prurigo nodularis, a condition that causes intense itching and hard bumps on the skin. The main goal is to see if the drug can significantly reduce itch severity over 12 weeks compared to a placebo. Par…
Matched conditions: PRURIGO NODULARIS
Phase: PHASE2 • Sponsor: Celldex Therapeutics • Aim: Symptom relief
Last updated May 18, 2026 12:07 UTC
-
New drug shows promise for severe itch in Long-Term trial
Symptom relief OngoingThis study tests the long-term safety of nemolizumab in about 500 adults with prurigo nodularis, a condition causing intense itching and skin bumps. Participants who completed earlier nemolizumab trials will receive the drug for up to 184 weeks. Researchers will track side effect…
Matched conditions: PRURIGO NODULARIS
Phase: PHASE3 • Sponsor: Galderma R&D • Aim: Symptom relief
Last updated May 14, 2026 12:02 UTC